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Aim: This retrospective study compared the
bacteriological and clinical presentation of tuber-
culosis and the outcome of treatment in immi-
grants notified for TB after active screening by
chest X-ray at the border with other patients de-
tected by passive screening. 
Design: Retrospective study of all patients no-
tified for TB in Vaud Canton in 2001 and 2002.
Results: In Vaud Canton 78% of the 179 pa-
tients notified for TB were foreign-born. Among
71 asylum seekers actively screened at the border,
49.3% [CI 37.4–61.2] were symptom-free vs
17.6% [CI 10.3–24.9] among 108 passively
screened patients. In the passively screened group,
the proportion of asymptomatic patients was
15.4% for Swiss patients, 8.6% for foreign work-
ers, and 29.4% for other foreigners. The average
duration of symptoms before diagnosis among
patients with complaints was 2 months in actively
screened foreign-born, compared to 2.5 months in
passively screened patients (no significant differ-
ence by Wilcoxon-Mann-Whitney test). The pro-
portion of pulmonary TB cases with positive smear
or culture was 63.4% in actively screened patients
vs 70.4% in passively detected cases. Among activ-
ely screened patients with bacteriological confir-
mation, 42.2% [CI 27.2–57.2] were asymptomatic
compared to 13% [CI 5.31–20.7] for passively
screened patients. Considering only smear positive
patients, the proportion of symptom-free patients
was 22.2% [CI 9.6–34.8] in 45 actively screened
cases vs 11.7% [4.4–19.0] for 77 passive screening.
Cure and treatment completion rate for new cases
reached 88% for foreign workers, 83% for asylum
seekers, 85% for Swiss patients, and 78% for other
foreigners.
Conclusions: Actively screened patients were
more frequently asymptomatic than passively de-
tected cases, even when considering only patients
with bacteriological confirmation. The active
screening by chest X-ray of an immigrant popula-
tion with a high prevalence of tuberculosis allows
the early detection and treatment of tuberculosis.
This may contribute to the protection of the resi-
dent population from infection. The outcome of
treatment for tuberculosis was satisfactory in all
population groups.
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Like in many other countries in Western Eu-
rope, where the incidence of tuberculosis is low,
the disease is mainly observed in Switzerland
among elderly persons in the native population
and among the young in the foreign-born popula-
tion. Despite the increasing proportion of foreign-
born patients among TB cases, the total number
of notifications is decreasing every year in Switzer-
land (1134 in 1991 and 611 in 2001). A temporary
increase was observed in 2002, which reversed in
2003 [1]. 
Migration makes tuberculosis a public health
problem. People move from high prevalence to
low prevalence countries, where the illness is close
to its elimination phase. Because of their origin,
living or travelling conditions, immigrants are
more likely to have active or latent tuberculosis. In
Switzerland, immigrants coming from countries
other than the European Community, USA,
Canada, Australia and New Zealand who register
as asylum seekers in one of the five State registra-
tion centres at the border (Vallorbe, Basel, Kreuz-
lingen, Altstätten and Chiasso) undergo a health
control, which includes a tuberculin skin test and
a chest X-Ray (except for children younger than 15
years and for pregnant women), to detect any pos-
sible sign of pulmonary TB [2, 3]. Foreign work-
ers from the same countries have to pass a Chest
X-ray only. Patients with abnormal chest X-Rays
are sent to a local hospital for further examination.
Immigrants unable to speak French or English re-
ceive the assistance from translators. Patients with
positive smears will be isolated and treated until
the smear becomes negative to avoid any spread of
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the illness. Most immigrants with tuberculosis de-
tected at the border Centre of Vallorbe stayed in
Vaud Canton for further treatment.
Foreign students, tourists and illegal immi-
grants are not screened as they enter Switzerland.
In this group of foreigners, TB can only be iden-
tified if they seek medical attention, which means
that for them the screening is passive, as for the
Swiss population [4].
Studies have demonstrated that immigrants
with tuberculosis detected by active screening have
shorter symptomatic and infectious periods and
that an important proportion of actively screened
patients with positive culture did not complain of
symptoms [5].
This retrospective study compared the bacte-
riological and clinical presentation of tuberculosis
and the outcome of treatment in immigrants noti-
fied for TB after active screening at the border
with other patients detected by passive screening. 
Methods
Data on tuberculosis patients notified in Vaud Can-
ton were obtained from the Swiss Federal Office of Pub-
lic Health. Vaud Canton, representing about 9% of the
Swiss population, was selected because it is the main port
of entry for immigrants in Switzerland, therefore allow-
ing the constitution of a group of actively screened cases
to be compared with the cases notified from the resident
population. Information about demography, legal status,
microbiology (smear and culture results), type of disease,
duration of symptoms before treatment and outcome of
treatment were searched for in hospital registers, espe-
cially the hospital at the border, university hospitals and
in private medical practices. A questionnaire was sent to
the physicians in charge of treatment. If the information
was incomplete, an office visit was made. All cases were
retrospectively analysed between May 2003 and February
2004, i.e. more than one year after notification in order to
assess the outcome of treatment. 
Information about the Swiss demography, immigra-
tion and epidemiology of tuberculosis in Switzerland, was
found at the Swiss Federal Office for Statistics, at the Swiss
Federal Office for Justice and at the Swiss Federal Office
of Public Health.
This study compared the actively screened TB cases
(new immigrants applying for asylum in Switzerland) with
all other patients detected by passive screening (Swiss TB
cases, resident foreign workers, and other foreigners in-
cluding tourists, students, illegal immigrants as well as 11
asylum seekers detected by passive screening after entry in
Switzerland). The interval between beginning of symp-
toms and initiation of treatment between actively and pas-
sively screened patients was compared, considering that all
immigrants with positive smear and most of those with
symptoms were started on treatment within a few days
after entry in Switzerland.
Because many patients mentioned a prior treatment
for TB but were unable to give any detail about drug ther-
apy, in each screening group the proportion of new cases
(never treated), of cases with undocumented (complete or
incomplete) prior treatment, of cases with documented
prior treatment and of cases without information about
prior treatment were considered separately. Due to miss-
ing information about prior treatment prescribed, true re-
lapses (i.e. recurrence of TB after complete cure) and pro-
gressive disease after incomplete treatment could not be
differentiated. Therefore, these categories of patients
were grouped under the single denomination of “retreat-
ment”.
Outcome of treatment was defined according to the
WHO categories. “Cured” are patients with a docu-
mented conversion of culture. “Completed” are patients
who completed treatment but have no documented cul-
ture conversion. “Death” applies to patients who died
from any causes before the end of the treatment. “Failure”
are patients with a persistently positive culture or a culture
which becomes newly positive after 5 or more months of
treatment. “Default” (abandon) relates to patients who
stop taking medication for 2 or more consecutive months,
those who fail to complete treatment within 9 months for
a 6 month treatment regimen or within 12 months for a 
9 months regimen, or those with a drug intake <80%.
“Transferred” are patients referred to other clinicians for
treatment where information on treatment outcome can-
not be obtained. A “successful outcome” is the sum of
cured and completely treated patients. 
Data were analysed with the non-parametric Wil-
coxon-Mann-Whitney test for the duration of symptoms
between actively and passively screened populations and
with descriptive statistics for the proportion of symptom-
free patients in both groups.
Results
In 2001 and 2002, approximately 7 250 000
people lived in Switzerland. The incidence of TB
was 8.4/100 000 in 2001 and 9/100 000 in 2002.
The number of inhabitants in Vaud Canton in
2001 and 2002 was 620 300. The incidence of TB
is higher than the Swiss average for these years,
with 13/100 000 in 2001 and 16/100 000 in 2002.
During both years, Vaud Canton reported 14% of
Swiss TB cases. During this period, 15 519 immi-
grants were registered at the immigration centre
in Vallorbe, of which 13 507 were actively screened
by Chest-X-ray. 2012 immigrants were not
screened (children and pregnant women).
In 2001 and 2002, 179 patients were notified
for tuberculosis in Vaud Canton (80 in 2001 and
99 in 2002). There were 114 male (63.7%). The
distribution of groups is reported in figure 1.
Among foreigners, 67 were from Africa (48%), 16
from Asia (11%), 37 from Eastern Europe (27%)
and 20 from Western Europe and other countries
(14%). The median age is lower for all groups of
foreigners than for Swiss patients (fig. 2).
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There were 132 new cases (73%), 34 with a
history of undocumented, complete or incomplete
prior treatment (19%), 12 patients with unknown
prior history of treatment (7%) and 1 treatment
after interruption (table 1). Among the 132 new
cases, there were 66 smear-positive pulmonary
TB, 30 culture-positive pulmonary TB, 14 cul-
ture-negative pulmonary TB and 22 extra pul-
monary TB (EPTB). Miliary TB was observed in
4 patients, urinary tract TB in 3 patients, peri-
toneal TB in 2 patients and there were single cases
of bronchial, adrenal and hepatic TB. The propor-
tion of bacteriologically proven cases (positive
smear and/or culture) among new pulmonary TB
cases was 77% in actively screened patients versus
94% in passively detected cases. Including retreat-
ments, these proportions  were 83% and 95%.
Tuberculosis was diagnosed by active screen-
ing at the border in 71 asylum seekers (40%) (525
cases for 100 000 examinations), in public hospi-
tals for 32 patients (18%) and in the private med-
ical sector for 76 patients (42%). The majority of
Swiss patients (32) and an important number of
foreign workers (20) were detected in the private
medical sector, along with some asylum seekers
where tuberculosis was discovered long after entry
in Switzerland (11) and other foreigners (13).
In patients with complaints, the average dura-
tion of symptoms before notification and treat-
ment was similar among immigrants actively
Figure 1
TB cases notified in
Vaud Canton in 2001
and 2002, by screen-
ing procedure.
0
10
20
30
40
50
60
0-9
29
30-
39
40-
49
50-
59
60-
69
70-
79
80-
89
90-
99
Swiss patients
(median age 64 years)
Foreign patients
(median age 29 years)
N    
Age (years)
20-
19
10-
Figure 2
Age distribution 
of foreign and Swiss
TB patients in 2001
and 2002 in Vaud
(CH).
active screening passive screening
N % N %
new Pulmonary TB (S+ / C±) 21 30 45 42
new Pulmonary TB (S– / C+) 14 20 16 15
new Pulmonary TB (S– / C–) 10 14 4 4
new Extra-pulmonary TB 6 8 16 15
undocumented prior treatment 14 20 20 19
retreatment after interruption 0 0 1 1
unknown prior history 6 8 6 6
total 71 100 108 100
Table 1
Category of TB, by
screening procedure.
S: Sputum smear, 
C: sputum culture.
TB patients
N = 179
ACTIVE screening
N = 71
asylum seekers
(at entry)
N = 71
PASSIVE screening
N = 108
other foreigners
(migrants, tourists, students
asylum seekers, passively
screened after entry)
N = 34
foreign
workers
N = 35
Swiss
N = 39
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screened at the border (50.7% of the group), com-
pared to passively screened patients (82.4%) (2
months vs 2.5 months). Anti-tuberculosis medica-
tion was started within a month of stay in Switzer-
land for 72% of actively screened TB patients.
Table 2 reports the characteristics of all actively
and passively screened TB cases.
Among actively screened patients, 49.3% [CI
37.4–61.2] were symptom-free vs 17.6% [CI
10.3–24.9] among passively screened patients.
Among patients with pulmonary TB confirmed by
culture, 42.2% [CI 27.2–57.2] of actively screened
patients had no complaints compared to 13% [CI
5.31–20.7] for passively screened patients. Re-
stricting to patients with positive smear, the pro-
portions were respectively 22.2% [CI 9.6–34.8]
and 11.7% [CI 4.4–19.0]. The proportion of 
symptom-free patients was lower among Swiss pa-
tients (13%) and other foreigners (12%) and very
low among foreign workers (3%) (fig. 3).
Overall, for the new and retreament cases (ex-
cluding 12 cases with missing final information),
the treatment was successful in 83% of the pa-
tients. The results were similar in the actively and
passively screened group (fig. 4). Cure and treat-
ment completion rate for new cases reached 88%
for foreign workers, 83% for asylum seekers and
85% for Swiss patients, but only 78% for other for-
eigners. For patients in retreatment, the success
rate was 82%.
screening active passive
category AS FW Other CH
number 71 35 34 39
female % 21 37 56 46
median age (years) 26 34 31 64
symptomatic patients 51% 91% 71% 85%
infectious cases (S+ and/or C+ pulmonary TB) 63% 74% 65% 72%
Table 2
Demographic data 
of TB cases, by legal
status and screening
procedure. AS: asy-
lum seekers actively
screened, FW: for-
eign workers, Other:
illegal immigrants,
students, tourists,
asylum seekers 
passively screened,
CH: Swiss patients.
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Figure 3
Proportion of and
asymptomatic 
patients, by bacterio-
logical result, for 
the whole group, 
patients with culture-
positive pulmonary
TB and smear-posi-
tive pulmonary 
TB (mean with 95%
confidence interval).
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Figure 4
Outcome of treat-
ment of TB, by
screening procedure
(all cases, including
retreatment but ex-
cluding 12 cases with
missing final infor-
mation). “Cured”: pa-
tient with bacterio-
logical proof of nega-
tivation. “Com-
pleted”: patients re-
ceiving a complete
course of antituber-
culosis treatment,
without bacteriolo-
gical proof of nega-
tivation. The sum of
“cured” and “Com-
pleted” is regarded
as treatment success.
“Failure” is the
persistence of posi-
tive culture after 5
months of treatment.
“Death” is the lethal
issue from whatever
cause during antitu-
berculosis treatment.
“Default” refers to
patients missing 2
months of treatment
before completion.
“Transfers” are pa-
tients leaving the
country during treat-
ment, without avail-
able information on
further treatment.
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The incidence of TB in Vaud Canton was 1.5
times higher than the Swiss average rate in 2001
and 1.7 times higher in 2002, due to the presence
of the registration centre at the border, where asy-
lum seekers are screened. The rate was 13/100 000
in 2001 and 16/100 000 in 2002. Foreigners, ap-
proximately half of which were asylum seekers,
represented 20% of the population living in
Switzerland but 75% of the TB population. The
Swiss population is much older than the foreign
population. In our study, the majority of foreign-
ers originated from Africa or Eastern European
countries. 
Active screening for tuberculosis has been ex-
tensively used in industrialized Countries since the
middle of the 20th Century, mainly by mass minia-
ture Chest X-ray screening, with the aim of dis-
covering the infectious cases as early as possible
and isolate them from the general population.
Since the introduction of efficient antituberculous
treatment, which has cured the majority of patients
and shortened the infectious period, mass screen-
ing has been abandoned in most countries with a
low or medium incidence rate. It is still used in
some countries with high incidence rates, particu-
larly in Eastern Europe, and in selected population
groups, like immigrants from developing coun-
tries. A report by a European task force in 1994
highlighted the importance of a nationwide system
for the screening and medical assessment of immi-
grants to avoid the transmission of tuberculosis to
other immigrants and to the local population [6].
A Canadian study demonstrated that screening
using chest X-rays and tuberculin skin tests are
cost-effective methods for the detection of TB in
population groups with high incidence, like new
immigrants [7], although this position is currently
questioned [8]. 
Active screening allows the detection of TB at
an earlier stage than passive screening, before ex-
tensive destruction of lung parenchyma and the
formation of cavities with a high bacterial content
has occurred and give rise to obvious clinical symp-
toms. This is expected to shorten the duration of
the period of possible transmission of infectious
particles to healthy bystanders. It is therefore not
surprising that a larger proportion of the patients
are still symptom-free in the actively screened
group (49.3%) than in the other groups (17.6%).
Twenty-two percent of actively screened immi-
grants with positive smear are symptom-free, and
42.2% of those with positive culture. A prior Swiss
study already demonstrated that a high proportion
of patients with TB were asymptomatic [9]. For
symptomatic patients, the duration of symptoms
was similar in both groups. Immigrants detected
after entry in Switzerland usually had a normal or
unremarkable chest X-ray at the border and can be
assumed to present a progression or reactivation of
a latent infection which was inapparent at entry.
We cannot exclude that some cases among immi-
grants with a normal chest X-ray at entry may have
been infected in Switzerland, but we have no doc-
umented evidence for it.
Contrary to the expectations, the proportion
of bacteriological confirmation by smear or culture
among new pulmonary TB and retreatment cases
detected actively is high, and not significantly
lower than among passively screened patients.
This could mean that even actively screened pa-
tients had already reached a moderately advanced
stage of disease and may have transmitted TB, if
not detected. In a Dutch study, immigrants de-
tected by active screening were less frequently bac-
teriologically active (OR 0.5), had less symptoms,
were less frequently hospitalised (OR 0.2) and had
probably less time and opportunity to transmit TB
to other people than immigrants presenting spon-
taneously for examination [10]. The main differ-
ence is that in our study we compared immigrants
screened at the border on the day of arrival in
Switzerland with all other patients with TB, in-
cluding Swiss and resident foreign workers and not
only immigrants. In a recent study, TB cases de-
tected actively among Canadian Plains Aborigines
were younger, had less symptoms and were less
infectious than cases detected passively [11]. The
difference with our study is that the Canadian
Aborigines were mainly detected actively during
contact tracing or routine school examination and
were therefore younger than adults presenting
with symptoms. Due to age, a very limited propor-
tion of them had bacteriologically confirmed pul-
monary TB. In our study, the median age of asy-
lum seekers, foreign workers and other foreigners
is not different (26, 34 and 31 years). Only the
Swiss TB patients are older (median age 64). Our
study could therefore indicate that actively de-
tected patients with tuberculosis may have a simi-
lar tendency to progression to extensive disease
than passively detected patients and do not repre-
sent a group of cases with fibrotic lesions only or
undergoing possible spontaneous regression.
The overall favourable outcome of treatment
of tuberculosis is close to the WHO target of 85%
but did not reach the expected target for industri-
alized countries. Among the reasons for this is the
fact that Swiss patients are older than foreign pa-
tients and have therefore a higher death rate (from
TB or with TB as a complication of an underlying
illness). Of the 8 deaths that occurred during this
study, 7 were Swiss patients, of whom 4 were in re-
treatment, but no case had multidrug-resistent
TB. Another reason is that foreigners, especially
asylum seekers and the “other” group, frequently
disappeared during treatment by transfer to other
parts of Switzerland or return to their country of
origin. Similar results were observed in a survey of
outcome of treatment in Switzerland in 1996,
where the success rate (sum of patients cured and
Discussion
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completely treated) was satisfactory (79%) with a
similar proportion of success for asylum seekers
(81%), foreign workers (89%) and Swiss patients
(80%) but lower for foreigners without a legal
status (54%) [12]. Compared with the outcome of
patients treated for TB in Vaud Canton between
1988 and 1992, the success rate increased in 2001
& 2002 [13]. This may partly be due to the wider
use of directly observed therapy (DOT) [14].
This study has several limitations. First, it is a
retrospective study relying on the medical records
from hospitals and medical offices, without control
on the accuracy of reporting of symptoms. As the
data rely on information given by the patients, who
frequently cannot express themselves in the local
language or have another representation of health
and disease, they may be unreliable. The fact that
new immigrants usually have the assistance of a
translator at entry in Switzerland gives some assur-
ance. As we were able to study the records of all
cases of TB notified during the period considered,
we can exclude a selection bias. Second, recently
infected immigrants may still have a negative tu-
berculin skin test and a normal chest X-Ray on ex-
amination at the border and develop tuberculosis
at a later time. As the number of cases detected pas-
sively among immigrants over the years after entry
is much lower than the number of immigrants de-
tected with tuberculosis on entry at the border, we
assumed that progression of disease after entry is
an infrequent event. It is also known that some im-
migrants applying for asylum were already staying
in Switzerland before being registered. The dura-
tion of stay in Switzerland is, therefore, probably
underestimated. Finally, we did not perform a
cost-effectiveness analysis of active versus passive
screening. It is possible that the yield of active
screening is higher in immigrants groups with a
very high incidence rate of tuberculosis and lower
in groups with a moderate rate, but this remains to
be demonstrated. For practical reasons, the
screening programme at the border includes all
immigrants, regardless of their origin.
Conclusion
The active screening of an immigrant popula-
tion with a high prevalence of tuberculosis allows
the early detection and treatment of tuberculosis,
in a state where many patients still have no com-
plaints, in spite of being bacteriologically active.
This may contribute to the protection of the resi-
dent population from infection. The outcome of
treatment for tuberculosis was satisfactory in all
population groups.
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